Dynavax (DVAX) Posts Q2 Loss, Shares Drop

Dynavax Technologies Corp. (DVAX) shares fell 9 percent in Monday morning. The biotech company developing novel products to prevent and treat infectious diseases said Q2 revenues fell 86% year-over-year to $2.2 million versus Wall Street’s $3.4 million estimates. The company’s losses totaled $28.0 million, or 34 cents a share, in the second quarter, compared [...]